MARCUCCI, ROSSELLA
 Distribuzione geografica
Continente #
NA - Nord America 27.370
EU - Europa 20.943
AS - Asia 11.856
SA - Sud America 1.891
Continente sconosciuto - Info sul continente non disponibili 655
AF - Africa 323
OC - Oceania 209
Totale 63.247
Nazione #
US - Stati Uniti d'America 26.856
PL - Polonia 6.071
RU - Federazione Russa 5.359
IT - Italia 4.367
SG - Singapore 3.434
CN - Cina 2.640
HK - Hong Kong 1.691
BR - Brasile 1.532
VN - Vietnam 1.364
IE - Irlanda 1.263
KR - Corea 1.073
SE - Svezia 967
DE - Germania 667
FI - Finlandia 525
FR - Francia 513
UA - Ucraina 422
IN - India 370
GB - Regno Unito 347
CA - Canada 320
BD - Bangladesh 311
AU - Australia 207
ID - Indonesia 174
JP - Giappone 157
JO - Giordania 138
AR - Argentina 136
NL - Olanda 130
TR - Turchia 100
IQ - Iraq 81
MX - Messico 78
ES - Italia 71
EC - Ecuador 65
CI - Costa d'Avorio 64
ZA - Sudafrica 48
PK - Pakistan 47
BE - Belgio 42
MA - Marocco 40
CH - Svizzera 39
SA - Arabia Saudita 36
NG - Nigeria 34
CO - Colombia 33
PY - Paraguay 32
VE - Venezuela 32
CZ - Repubblica Ceca 26
TN - Tunisia 26
TW - Taiwan 26
UZ - Uzbekistan 25
AT - Austria 24
JM - Giamaica 24
PE - Perù 24
CL - Cile 23
PH - Filippine 20
DZ - Algeria 18
SC - Seychelles 18
HN - Honduras 17
OM - Oman 17
CR - Costa Rica 16
EG - Egitto 16
KE - Kenya 16
MY - Malesia 16
AE - Emirati Arabi Uniti 14
NP - Nepal 14
AZ - Azerbaigian 12
BJ - Benin 12
LT - Lituania 12
UY - Uruguay 12
RO - Romania 11
SK - Slovacchia (Repubblica Slovacca) 11
IL - Israele 9
KG - Kirghizistan 9
SV - El Salvador 9
TT - Trinidad e Tobago 9
AL - Albania 8
DO - Repubblica Dominicana 8
KZ - Kazakistan 8
TH - Thailandia 8
BG - Bulgaria 7
GE - Georgia 7
GR - Grecia 7
IR - Iran 7
MM - Myanmar 7
PR - Porto Rico 7
RS - Serbia 7
SN - Senegal 7
LB - Libano 6
LV - Lettonia 6
PA - Panama 6
A1 - Anonimo 5
BY - Bielorussia 5
DK - Danimarca 5
GT - Guatemala 5
HR - Croazia 5
MU - Mauritius 5
PS - Palestinian Territory 5
QA - Qatar 5
UG - Uganda 5
ET - Etiopia 4
HU - Ungheria 4
NO - Norvegia 4
PT - Portogallo 4
SI - Slovenia 4
Totale 62.533
Città #
Warsaw 6.056
Santa Clara 4.889
Ashburn 3.208
Singapore 2.435
Fairfield 2.378
Hong Kong 1.398
Dublin 1.258
Chandler 1.115
Woodbridge 1.109
Seoul 1.053
Seattle 986
Houston 881
San Jose 835
Cambridge 829
Wilmington 817
Milan 729
Florence 648
Jacksonville 609
Beijing 566
Council Bluffs 538
Hefei 524
Los Angeles 467
Ann Arbor 429
Ho Chi Minh City 421
Altamura 418
Lawrence 406
Rome 361
Princeton 356
Lauterbourg 326
Buffalo 323
The Dalles 295
Dallas 291
Moscow 284
Hanoi 277
New York 250
Boston 231
Helsinki 200
Mumbai 200
Medford 189
Boardman 185
Melbourne 180
Munich 178
San Diego 146
Tokyo 144
Shanghai 132
São Paulo 131
Jakarta 122
Naples 111
Kent 101
Paris 88
Clifton 79
Orem 79
Turin 79
Columbus 78
Toronto 78
London 77
Phoenix 77
Dong Ket 76
Frankfurt am Main 76
Da Nang 69
Bologna 68
Norwalk 67
Montreal 65
Turku 64
Abidjan 63
Chicago 62
Falls Church 58
Redondo Beach 56
Haiphong 55
Palermo 53
Amsterdam 49
Brooklyn 49
Atlanta 48
Lappeenranta 46
Rio de Janeiro 46
Figino 43
San Francisco 43
Guangzhou 40
Izmir 39
Belo Horizonte 38
Denver 38
Brussels 36
Andover 34
Bari 34
Chennai 34
Hillsboro 34
Miano 34
Nuremberg 34
Brasília 33
Yubileyny 33
Tianjin 29
Venice 29
Verona 29
Abuja 28
Baghdad 28
Bern 28
Hải Dương 28
Shenzhen 28
Bengaluru 26
North Bergen 26
Totale 42.546
Nome #
Residual platelet reactivity on aspirin therapy and recurrent cardiovascular events. A meta-analysis 640
Validation of a literature-based adherence score to Mediterranean diet: the MEDI-LITE score 449
A khorasan wheat-based replacement diet improves risk profile of patients with type 2 diabetes mellitus (T2DM): a randomized crossover trial 425
Evaluation of traditional and emerging cardiovascular risk factors in patients with non-arteritic anterior ischemic optic neuroparty: a case-control study 414
High-throughput multiplex single-nucleotide polymorphism (SNP) analysis in genes involved in methionine metabolism 389
CLOCK gene polymorphisms and quality of aging in a cohort of nonagenarians – The MUGELLO Study 389
Erythrocyte oxidative stress is associated with cell deformability in patients with retinal vein occlusion 381
High on-treatment platelet reactivity by ADP and increased risk of MACE in good clopidogrel metabolizers. 367
Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events. 361
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 359
High platelet turnover and reactivity in renal transplant recipients patients 354
Clopidogrel non-responsiveness and risk of cardiovascular morbidity. An updated meta-analysis 352
Clinical events beyond one year after an acute coronary syndrome: Insights from the RECLOSE 2-ACS study 351
Angiotensi-converting enzyme DD genotype, angiotensin type 1 receptor CC genotype, and hyperhomocysteinmeia increase first-trimester fetal-loss susceptibility 342
Current status of clopidogrel pharmacogenomics. 336
High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI 335
Effect of blood hematocrit and erythrocyte deformability on adenosine 5' -diphosphate platelet reactivity in patients with acute coronary syndromes on dual antiplatelet therapy 326
Bleeding events and maintenance dose of prasugrel: BLESS pilot study 320
Increased homocysteine and lipoprotein(a) levels highlight systemic atherosclerotic burden in patients with a history of acute coronary syndromes 319
Mediterranean versus vegetarian diet for cardiovascular disease prevention (the CARDIVEG study): Study protocol for a randomized controlled trial 316
Bioequivalence in the real world is a complex challenge: the case of clopidogrel 315
Lipoprotein(a) as a Risk Factor for Venous Thromboembolism: A Systematic Review and Meta-analysis of the Literature 315
Oxidative Modification of Fibrinogen Is Associated With Altered Function and Structure in the Subacute Phase of Myocardial Infarction. 314
Inflammatory and antioxidant pattern unbalance in "clopidogrel-resistant" patients during acute coronary syndrome. 314
Role of C677T and A1298C MTHFR, A2756G MTR and -786 C/T eNOS gene polymorphisms in atrial fibrillation susceptibility 312
Platelet aggregability is modulated by eNOS locus in non-type 2 diabetic patients with acute coronary syndrome 312
S38G single-nucleotide polymorphism at the KCNE1 locus is associated with heart failure 312
Relation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosis 311
PPARgamma promoter polymorphisms and acute coronary syndromes 310
High lipoprotein (a) levels are associated with an increased risk of retinal vein occlusion 302
Lipoprotein (a) and venous thromboembolism in adults: a meta-analysis 293
Role of glycoprotein Ia gene polymorphisms in determinino platelet function in myocardial infarction patients undergoing percutaneous coronary intervention of dual antiplatelet treatment 293
Residual platelet reactivity is associated with clinical and laboratory characteristics in patients with ischemic heart disease undergoing PCI on dual antiplatelet therapy 290
Predicting Mortality Risk in Older Hospitalized Persons With COVID-19: A Comparison of the COVID-19 Mortality Risk Score with Frailty and Disability 290
Lone and secondary nonvalvular atrial fibrillation: role of a genetic susceptibility 289
Relationship between exercise capacity, endothelial progenitor cells and cytochemokines in patients undergoing cardiac rehabilitation. 286
Apolipoprotein(a) kringle-IV type 2 copy number variation is associated with venous thromboembolism 286
Symptomatic efficacy of buckwheat products in Non-Celiac Gluten Sensitivity (NCGS) 286
The balance between pro- and anti-infilammatory cytokines is associated with platelet aggregability in acute coronary syndrome patients 285
High sensitivity C-reactive protein predicts the development of new carotid artery plaques in older persons 281
Residual thrombin potential predicts cardiovascular death in acute coronary syndrome patients undergoing percutaneous coronary intervention 280
Platelet and leukocyte ROS production and lipoperoxidation are associated with high platelet reactivity in Non-ST elevation myocardial infarction (NSTEMI) patients on dual antiplatelet treatment 279
Lower homocysteine levels in renal transplant recipients treated with everolimus: a possible link with a decreased cardiovascular risk? 278
Risk of bleeding in very old atrial fibrillation patients on warfarin: Relationship with ageing and CHADS(2) score 272
Thrombotic events in high risk patients are predicted by evaluating different pathways of platelet function. 266
Relation of CYP2C19 loss-of-function polymorphism to the occurrence of stent thrombosis 261
Effects of vegetarian versus Mediterranean diet on kidney function: Findings from the CARDIVEG study 259
Influence of a 3-month low-calorie Mediterranean diet compared to the vegetarian diet on human gut microbiota and SCFA: The CARDIVEG study 256
NMR-based metabolomics identifies patients at high risk of death within two years after acute myocardial infarction in the AMI-Florence II cohort 249
Hign on treatment platelet reactivity by more than one agonist predicts 12-month follow-up cardiovascular death and non-fatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting 244
Role of TGFBR1 and TGFBR2 genetic variants in Marfan syndrome 244
Metabolomics by Nuclear Magnetic Resonance identifies patients with high risk of death within two years after a cardiovascular event: The case of the amiflorence II study 242
Role of biological markers for cerebral bleeding risk STRATification in patients with atrial fibrillation on oral anticoagulants for primary or secondary prevention of ischemic stroke (Strat-AF study): Study design and methodology 237
Low-Calorie Vegetarian Versus Mediterranean Diets for Reducing Body Weight and Improving Cardiovascular Risk Profile: CARDIVEG Study (Cardiovascular Prevention With Vegetarian Diet) 235
Effects of a 3-month dietary intervention with a lacto-ovo-vegetarian diet on vitamin B-12 levels in a group of omnivores: results from the CARDIVEG (Cardiovascular Prevention with Vegetarian Diet) study 229
Prognostic value of sepsis-induced coagulation abnormalities: an early assessment in the emergency department 228
Cardiovascular benefits from ancient grain bread consumption: findings from a double-blinded randomized crossover intervention trial 225
Role of lipoprotein (a) and LPA KIV2 repeat polymorphism in bicuspid aortic valve stenosis and calcification: a proof of concept study 219
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper. 218
ACE insertion/deletion, but not -240A>T polymorphism, modulates the severity in heart failure 218
Infection with SARS-CoV-2 Variants Is Associated with Different Long COVID Phenotypes 215
ADAMTS-13 activity in the presence of elevated von Willebrand factor levels as a novel mechanism of residual platelet reactivity in high risk coronary patients on antiplatelet treatment 214
Gender effect on well-being of the oldest old: a survey of nonagenarians living in Tuscany: the Mugello study 212
Aging process, adherence to Mediterranean diet and nutritional status in a large cohort of nonagenarians: Effects on endothelial progenitor cells 211
Erythrocyte membrane fluidity alterations in sudden sensorineural hearing loss patients: The role of oxidative stress 210
Monoclonal Anti-PCSK9 Antibodies: Real-World Data 209
ACE DD genotype: an independent predisposition factor to venous thromboembolism. 208
A hypercoagulable and hypofibrinolytic state is detectable by global methods in patients with retinal vein occlusion. 208
Prognostic relevance of GRACE risk score in Takotsubo syndrome 208
Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis 207
Can CHA2DS2-VASc and HAS-BLED Foresee the Presence of Cerebral Microbleeds, Lacunar and Non-Lacunar Infarcts in Elderly Patients With Atrial Fibrillation? Data From Strat-AF Study 205
RISK FACTORS FOR CARDIOVASCULAR DISEASE IN RENAL TRANSPLANT RECIPIENTS: NEW INSIGHTS 203
A time course study of high on treatment platelet reactivity in acute coronary syndrome male patients on dual antiplatelet therapy. 203
Effects of cryoablation and radiofrequency ablation on endothelial and blood clotting activation 203
Prevalence and predictors of dual antiplatelet therapy prolongation beyond one year in patients with acute coronary syndrome 203
The genes that codify angiotensin converting enzyme and type 1 receptor for angiotensin II have a different effect on longevity 201
Assessment of platelet function on whole blood by multiple electrode aggregometry in high-risk patients with coronary artery disease receiving antiplatelet therapy 200
Clinical risk score to predict in-hospital mortality in COVID-19 patients: a retrospective cohort study 199
Platelet Reactivity in Hepatitis C Virus-Infected Patients on Dual Antiplatelet Therapy for Acute Coronary Syndrome 199
Sars-CoV-2 induced coagulopathy and prognosis in hospitalized patients: A snapshot from Italy 199
Association of Body Fat With Health-Related Quality of Life and Depression in Nonagenarians: The Mugello Study 198
Atrial septal defect closure and de novo migraine: Exclusive ticlopidine efficacy 197
The high prevalence of thermolabile 5,10 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease (CAD) 197
Clinical and echocardiographic predictors of postoperative atrial fibrillation in lung surgery: the role of left atrial remodelling 196
Cytochrome P450 2C19*2 polymorphism and cardiovascular recurrences in patients taking clopidogrel: a meta-analysis 196
Mediterranean, but not lacto-ovo-vegetarian, diet positively influence circulating progenitor cells for cardiovascular prevention: The CARDIVEG study 196
Results of comprehensive cardiovascular diagnostic work-up in HIV positive patients 196
The serum metabolomic profiles of atrial fibrillation patients treated with direct oral anticoagulants or vitamin K antagonists 193
Natural history of anti-PF4 antibodies in patients with vaccine-induced immune thrombocytopenia and thrombosis 193
Circulating endothelial and progenitor cells in age-related macular degeneration 193
Ticagrelor crushed tablets administration in STEMI patients: The MOJITO study 193
Analysis of Metabolite and Lipid Association Networks Reveals Molecular Mechanisms Associated with 3-Month Mortality and Poor Functional Outcomes in Patients with Acute Ischemic Stroke after Thrombolytic Treatment with Recombinant Tissue Plasminogen Activator 193
Antiplatelets in acute coronary syndrome: personal perspectives. 192
Altered fibrin susceptibility to plasmin-induced lysis in coronary artery disease patients: relationships with oxidative stress 191
High on-aspirin platelet reactivity predicts cardiac death in acute coronary syndrome patients undergoing PCI 191
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9) 190
Fibrinolytic inhibitors and fibrin characteristics determine a hypofibrinolytic state in patients with pulmonary embolism. 190
TISSUE FACTOR AND HOMOCYSTEINE LEVELS IN ISCHEMIC HEART DISEASE ARE ASSOCIATED WITH ANGIOGRAPHICALLY DOCUMENTED CLINICAL RECURRENCES AFTER CORONARY ANGIOPLASTY 189
Important risk factors for venous thromboembolism. Analysis of 758 patients studied at a thrombosis center 189
Low vitamin B6 and folic acid levels are associated with retinal vein occlusion independently of homocysteine levels. 189
Totale 26.439
Categoria #
all - tutte 172.712
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 172.712


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.174 0 193 176 96 57 133 92 192 117 131 325 662
2022/20235.277 558 1.078 245 315 394 961 684 258 503 36 174 71
2023/20242.000 95 222 395 109 96 236 61 399 51 161 99 76
2024/202514.932 537 1.582 983 2.228 3.978 2.043 346 899 762 412 569 593
2025/202620.056 1.703 2.519 1.639 1.899 2.127 843 2.271 1.136 1.179 1.172 919 2.649
2026/20271.711 1.032 679 0 0 0 0 0 0 0 0 0 0
Totale 63.247